FDA.reportPublic FDA data

Vir Combination

Product NDC
43742-2036
11-digit product format
437422036
Labeler code
43742
Product ID
43742-2036_8df251cd-be49-44d3-b456-badf4ba1c4af
Type
HUMAN OTC DRUG
Nonproprietary name
Influenzinum (2020-2021), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode
Dosage form
LIQUID
Route
ORAL
Labeler
Deseret Biologicals, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2021-09-09
Marketing end
2026-10-01
Substance
HEPATITIS B VIRUS; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)
Active strength
33; 12; 12; 15; 15; 16; 18; 15; 12; 12; 12; 12 [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmacologic classes
Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Live Human Adenovirus Type 7 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]
NDC exclude flag
No
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Vir Combination

Active Ingredients#

Ingredient, Strength table
IngredientStrength
INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)33 [hp_X]/mL
INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_X]/mL
INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_C]/mL
INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)15 [hp_X]/mL
HUMAN HERPESVIRUS 115 [hp_X]/mL
HUMAN HERPESVIRUS 216 [hp_C]/mL
HUMAN HERPESVIRUS 618 [hp_X]/mL
HUMAN HERPESVIRUS 515 [hp_X]/mL
HEPATITIS B VIRUS12 [hp_X]/mL
HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN12 [hp_X]/mL
HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN12 [hp_X]/mL
HUMAN HERPESVIRUS 412 [hp_X]/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiNY1FF92M1E, P8ORN3UOM6, B93BQX9789, VEH9U90EHX, 22G38P19RL, 74J6DNH49U, 4IX4VP35CR, 7COI029E6K, 77H9EM77P7, FKD3DUK39I, TM54L796SN, 2A26YW7PNX

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
43742-2036-1Vir Combination30 mL in 1 BOTTLE, DROPPERLIQUID302

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43742-2036VIR COMBINATION (INFLUENZINUM (2020-2021), HERPES SIMPLEX 1 NOSODE, HERPES SIMPLEX 2 NOSODE, HUMAN HERPESVIRUS 6A, HUMAN HERPESVIRUS 6B, CYTOMEGALOVIRUS NOSODE, HEPATITIS B NOSODE, ADENOVIREN NOSODE, EPSTEIN-BARR VIRUS NOSODE) LIQUID [DESERET BIOLOGICALS, INC.]2Current NDC, Legacy NDC, 1 package rows20220203_d48d741e-c6b2-45bd-a102-9b793f62a53c.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
43742-2036-14374220360130 mL in 1 BOTTLE, DROPPER (43742-2036-1) 30 ml2021-09-092026-10-01NoNoCurrent